Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
FGEN FibroGen
- 0.408
- +0.005+1.26%
Close Feb 28 16:00 ET
- 0.405
- -0.003-0.78%
Post 20:01 ET
41.15MMarket Cap-0.33P/E (TTM)
0.421High0.376Low1.03MVolume0.382Open0.403Pre Close412.12KTurnover1.11%Turnover RatioLossP/E (Static)100.77MShares2.80052wk High-0.17P/B37.94MFloat Cap0.18052wk Low--Dividend TTM92.91MShs Float68.550Historical High--Div YieldTTM11.06%Amplitude0.180Historical Low0.399Avg Price1Lot Size
About FibroGen Company
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
Company Profile
SymbolFGEN
Company NameFibroGen
Listing DateNov 14, 2014
Issue Price18.00
Founded1993
CEOMr. Thane Wettig
MarketNASDAQ
Employees486
Fiscal Year Ends12-31
Address350 Bay Street,Suite 100-6009
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94133
Phone1-415-978-1200
Websitehttp://www.fibrogen.com
Company Executives
- Name
- Position
- Salary
- Thane Wettig
- Chief Executive Officer and Director
- 3.64M
- David DeLucia
- Chief Financial Officer
- --
- Christine Chung
- Senior Vice President, China Operations
- 3.11M
- James A. Schoeneck
- Chairman of the Board
- 499.58K
- Dr. Maykin Ho, PhD
- Independent Director
- 375.53K
- Dr. Aoife M. Brennan, M.B.
- Independent Director
- 373.03K
- Jeffrey L. Edwards
- Independent Director
- 385.53K
- Jeffrey W. Henderson
- Independent Director
- 370.53K